TN Bullock, DW Mullins, TA Colella, VH Engelhard. (2001) " Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice. " J Immunol 167. 5824-31 PMID: 11698456 | Abstract and Keywords
DW Mullins, SL Sheasley, RM Ream, TN Bullock, YX Fu, VH Engelhard. (2003) " Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. " J Exp Med 198. 1023-34 PMID: 14530375 DOI: 10.1084/jem.20021348 | Abstract and Keywords
RM Prins, SK Odesa, LM Liau. (2003) " Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. " Cancer Res 63. 8487-91 PMID: 14679014 | Abstract and Keywords
R Zeng, R Spolski, SE Finkelstein, S Oh, PE Kovanen, CS Hinrichs, CA Pise-Masison, MF Radonovich, JN Brady, NP Restifo, JA Berzofsky, WJ Leonard. (2005) " Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. " J Exp Med 201. 139-48 PMID: 15630141 DOI: 10.1084/jem.20041057 | Abstract and Keywords
LX Wang, R Li, G Yang, M Lim, A O'Hara, Y Chu, BA Fox, NP Restifo, WJ Urba, HM Hu. (2005) " Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing. " Cancer Res 65. 10569-77 PMID: 16288050 DOI: 10.1158/0008-5472.CAN-05-2117 | Abstract and Keywords
DW Mullins, VH Engelhard. (2006) " Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes. " J Immunol 176. 4535-42 PMID: 16585543 | Abstract and Keywords
XZ Shen, P Li, D Weiss, S Fuchs, HD Xiao, JA Adams, IR Williams, MR Capecchi, WR Taylor, KE Bernstein. (2007) " Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. " Am J Pathol 170. 2122-34 PMID: 17525278 | Abstract and Keywords
VV Parekh, S Lalani, S Kim, R Halder, M Azuma, H Yagita, V Kumar, L Wu, LV Kaer. (2009) " PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. " J Immunol 182. 2816-26 PMID: 19234176 DOI: 10.4049/jimmunol.0803648 | Abstract and Keywords